Dutasteride and its UK licence
Dutasteride is a prescription medicine that reduces dihydrotestosterone, or DHT. It may be considered for some men with male pattern hair loss, but in the UK its licensed indication is an enlarged prostate. Prescribing it for hair loss is therefore an off-label use of a medicine. That distinction should be explained before treatment starts.
Off-label does not mean there is no research. It means the prescriber is using the medicine outside its authorised indication and needs to judge whether that is appropriate for you. A stronger effect on a hormone is not, by itself, a reason to choose a medicine.
How it differs from finasteride
Dutasteride inhibits both type 1 and type 2 forms of 5-alpha reductase, the enzyme involved in converting testosterone to DHT. Finasteride mainly inhibits type 2. The aim in pattern hair loss is to reduce the hormonal effect on susceptible scalp follicles.
The UK Avodart product information explains that dutasteride clears slowly. With repeated dosing, its half-life is approximately three to five weeks: the amount in the body falls gradually rather than disappearing immediately after the last capsule. That matters when considering adverse effects or a change of treatment.
What the evidence means for a decision
The British Association of Dermatologists' male pattern hair loss leaflet includes dutasteride among other treatment options. It cautions that stronger suppression of DHT does not establish a convincing advantage over finasteride for everyone, and notes concerns about side effects. The decision is more complicated than choosing the medicine described online as the strongest.
When discussing evidence, ask which patients were studied, which outcome improved and how long follow-up lasted. A change in hair count in a measured patch is not the same as a completely restored hairline. A study can also leave unanswered questions about long-term tolerability and which patients should switch from another treatment.
Before-and-after photographs need the treatment history and follow-up dates to be meaningful. If a person also used minoxidil, had surgery or changed several treatments, the photograph cannot isolate the effect of dutasteride. Ask the clinician to explain the uncertainty as well as the possible benefit.
Who may discuss it with a clinician
A discussion may be appropriate for an adult man with confirmed pattern hair loss, particularly when an existing plan has not produced enough benefit. The first step is to check the diagnosis and what treatment has actually been used. A short or inconsistent trial of another medicine does not establish that it has failed.
Avodart must not be taken by women, children or adolescents, or by people with severe liver disease or relevant allergies, including soya or peanut allergy. Other liver problems also need to be disclosed. The Avodart patient leaflet sets out the exclusions and precautions.
Capsules, interactions and practical use
A prescriber must decide the regimen for off-label hair-loss treatment; there is no licensed hair-loss schedule to copy. Follow the prescription for your own product. Capsules should be swallowed whole, not opened or chewed, and a missed dose should not be replaced with a double dose.
Give the prescriber a full list of medicines and supplements. Some medicines can increase dutasteride exposure, including certain antifungals, HIV treatments and medicines such as verapamil or diltiazem. Do not combine finasteride and dutasteride or change dosing frequency on your own.
A scalp preparation is a different formulation. Oral research cannot simply be used to promise the same result or safety profile from a topical product, and there is no universal application schedule to copy from another patient.
Side effects and when to seek help
Possible adverse effects include reduced libido, erection or ejaculation problems and breast tenderness or enlargement. Some sexual effects have been reported after stopping; the medicine’s role in their persistence is uncertain. Breast lumps, nipple discharge and testicular pain or swelling should be discussed promptly with a doctor.
The MHRA updated its safety advice in May 2026. Dutasteride’s mood warning is precautionary because a related medicine, finasteride, has been associated with depression and suicidal thoughts. If you develop depression or suicidal thoughts while taking dutasteride, contact your doctor as soon as possible. Sexual side effects should also be reported. If you are at immediate risk of serious harm, call 999.
Seek emergency help for signs of a serious allergic reaction, such as breathing difficulty or swelling of the face, tongue or throat. Do not wait for a routine hair-loss review.
Pregnancy, fertility and blood tests
Women and children must avoid contact with leaking capsules because dutasteride can be absorbed through skin. Wash accidental skin contact with soap and water. The leaflet advises condom use to avoid exposing a partner who is or may be pregnant to semen. Discuss plans for a family before treatment.
Dutasteride can affect semen characteristics and may reduce fertility. It can also lower PSA, a marker used in prostate assessment. Tell the clinician arranging a PSA test that you take it so the result is interpreted appropriately.
Assessing results and the ongoing cost
A review timetable should reflect the treatment plan and your clinical circumstances. An advertised month-by-month result is not a guarantee that you will see the same change. Agree a review timetable, photograph the same scalp areas consistently, and report adverse effects as they arise.
Ask what you will pay for the medicine, prescribing assessment and follow-up, and what happens if treatment is stopped. An advertised capsule price may not include those services.
If the photographs show continuing loss, revisit the diagnosis and treatment plan. Adding more products without knowing why the first plan has failed makes both benefit and side effects harder to assess.
Alternatives and hair transplant planning
Finasteride and minoxidil have different roles and are covered in separate guides. Some people prefer styling changes, a hair system or no medical treatment. Those choices can be discussed without assuming that surgery is the next step.
A hair transplant moves a limited supply of donor hair follicles. It does not remove the need to consider future loss in surrounding hair. A consultation should address both the current appearance and what further thinning could mean for the overall plan.
Crown hair transplant results
Before-and-after photographs from Harley Street Hair Transplants. These show crown transplant results, not the effects of medication alone. Individual results vary.
Read about crown hair transplants.
Questions to settle before an off-label prescription
Ask why dutasteride is being considered for you and what alternatives have been discussed. The answer should relate to your diagnosis, previous treatment, preferences and medical history. A general claim that it blocks more DHT does not explain why the benefits are likely to outweigh the risks in your circumstances.
Bring the names and strengths of products you have already tried, how consistently you used them and why you stopped. Include side effects even if you are unsure they were related. A brief trial, an interrupted supply and a carefully monitored course are different histories; the prescriber needs to know which applies.
Our guide to the Norwood scale helps describe the distribution of male pattern hair loss. The scale cannot tell you whether dutasteride is suitable, or explain sudden diffuse shedding. If the pattern has changed unexpectedly, ask whether the diagnosis needs another look before adding or switching medicine.
Ask what monitoring will involve and who is responsible for it. Clarify when photographs will be compared, how to report a new symptom and how to obtain advice between appointments. The MHRA's off-label prescribing guidance includes responsibility for ongoing care, monitoring and follow-up.
It can help to write down a few questions before the appointment: What benefit is realistic? What would make us stop or change the plan? Who should I contact about mood or sexual symptoms? What happens if I want to try for a family? Having a clear contact route is more useful than being told to wait and see without a review plan.
Do not judge progress from differently lit photographs or hair styled to conceal thinning. Keep a small set of comparable images and discuss both the appearance and how you feel about treatment. A modest cosmetic change may be worthwhile to one person and insufficient to another; the decision should take your priorities into account.
There is no obligation to accept a prescription at the first consultation. Ask for written information if you want time to consider it. Choosing observation, camouflage or another suitable approach is a valid outcome of an informed discussion. The aim is a plan you understand and can review, rather than an escalating collection of products.
Questions and answers
Is dutasteride licensed for hair loss in the UK?
No. Its UK licence is for an enlarged prostate. Hair-loss prescribing is off-label and requires an individual prescribing decision.
Is dutasteride always better than finasteride?
No. One six-month trial found a greater average improvement in measured hair counts and width, but that does not establish the best choice for every person.
Can I use it to grow a beard?
The scalp hair-loss studies discussed here do not establish a beard-growth treatment. Do not use them to predict facial-hair results.
Can I switch from finasteride myself?
Speak to the prescriber first. The medicines are not interchangeable, and dutasteride remains in the body for much longer.
What if I am not seeing regrowth?
A review should consider stability as well as regrowth, whether the diagnosis is correct, the duration of treatment and any side effects. Do not increase treatment yourself.
Discuss your hair loss in Glasgow
Bring a list of current medicines and any dated photographs to your assessment. You can ask about the cause of thinning, what treatment could realistically achieve and whether a transplant is appropriate. Request a consultation with Glasgow Hair Transplant Clinics.